Bevacizumab rechallenge in glioblastoma patients with initial response to bevacizumab who later progress off therapy

被引：1
|
作者：
Balana, Carmen [1 ]
Estival, Anna [1 ]
Pineda, Estela [2 ]
机构：
[1] Catalan Inst Oncol, Ctra Canyet S-N, Badalona 08916, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF NEURO-ONCOLOGY | 2018年 / 139卷 / 03期
关键词：
D O I：
10.1007/s11060-018-2902-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：779 / 780
页数：2
相关论文
共 50 条
  • [1] Bevacizumab rechallenge in glioblastoma patients with initial response to bevacizumab who later progress off therapy
    Carmen Balana
    Anna Estival
    Estela Pineda
    [J]. Journal of Neuro-Oncology, 2018, 139 : 779 - 780
  • [2] Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy
    Bronnimann, Charlotte
    Izquierdo, Cristina
    Cartalat, Stephanie
    Thomas, Laure
    Joubert, Bastien
    Delpech, Laura
    Barritault, Marc
    Meyronet, David
    Honnorat, Jerome
    Ducray, Francois
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (01) : 141 - 145
  • [3] Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy
    Charlotte Bronnimann
    Cristina Izquierdo
    Stéphanie Cartalat
    Laure Thomas
    Bastien Joubert
    Laura Delpech
    Marc Barritault
    David Meyronet
    Jérôme Honnorat
    François Ducray
    [J]. Journal of Neuro-Oncology, 2018, 138 : 141 - 145
  • [4] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    D A Reardon
    J E Herndon
    K B Peters
    A Desjardins
    A Coan
    E Lou
    A L Sumrall
    S Turner
    E S Lipp
    S Sathornsumetee
    J N Rich
    J H Sampson
    A H Friedman
    S T Boulton
    D D Bigner
    H S Friedman
    J J Vredenburgh
    [J]. British Journal of Cancer, 2012, 107 : 1481 - 1487
  • [5] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    Reardon, D. A.
    Herndon, J. E., II
    Peters, K. B.
    Desjardins, A.
    Coan, A.
    Lou, E.
    Sumrall, A. L.
    Turner, S.
    Lipp, E. S.
    Sathornsumetee, S.
    Rich, J. N.
    Sampson, J. H.
    Friedman, A. H.
    Boulton, S. T.
    Bigner, D. D.
    Friedman, H. S.
    Vredenburgh, J. J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1481 - 1487
  • [6] RECHALLENGE WITH BEVACIZUMAB IN A LONG-TERM SURVIVOR WITH GLIOBLASTOMA
    Koeppen, S.
    Hense, J.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 51 - 52
  • [7] PRIMARY SPINAL CORD GLIOBLASTOMA: RESPONSE TO THERAPY WITH BEVACIZUMAB
    Walbert, Tobias
    Puduvalli, Vinay
    [J]. NEURO-ONCOLOGY, 2010, 12 : 44 - 44
  • [8] Bevacizumab antiangiogenic therapy for glioblastoma
    Junck, Larry
    [J]. NEUROLOGY, 2011, 76 (05) : 414 - 415
  • [9] Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts
    Lyon, Kristopher A.
    Huang, Jason H.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S802 - S805
  • [10] Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab
    Rahman, Rifaquat
    Hempfling, Kelly
    Norden, Andrew D.
    Reardon, David A.
    Nayak, Lakshmi
    Rinne, Mikael L.
    Beroukhim, Rameen
    Doherty, Lisa
    Ruland, Sandra
    Rai, Arun
    Rifenburg, Jennifer
    LaFrankie, Debra
    Alexander, Brian M.
    Huang, Raymond Y.
    Wen, Patrick Y.
    Lee, Eudocia Q.
    [J]. NEURO-ONCOLOGY, 2014, 16 (11) : 1523 - 1529
12345